XELLIA PHARMACEUTICALS ApS — Credit Rating and Financial Key Figures

XELLIA PHARMACEUTICALS ApS (CVR number: 61094628) is a company from KØBENHAVN. The company reported a net sales of 1599.4 mDKK in 2024, demonstrating a decline of -19.5 % compared to the previous year. The operating profit percentage was poor at -54.5 % (EBIT: -872.4 mDKK), while net earnings were 829 mDKK. The profitability of the company measured by Return on Assets (ROA) was 12.3 %, which can be considered good but Return on Equity (ROE) was 73.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 5.1 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. XELLIA PHARMACEUTICALS ApS's liquidity measured by quick ratio was 0.4 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.